Orchid Fertility pioneers non-invasive genetic testing for IVF in Dubai

UAE—Orchid Fertility Dubai, a leading clinic under Waha Health and located in Dubai Healthcare City, has introduced Non-Invasive Preimplantation Genetic Testing (niPGT), marking a significant advancement in the field of reproductive medicine.

This innovative technology is transforming the in vitro fertilization (IVF) experience by increasing the chances of a successful pregnancy and reducing the stress placed on embryos during the selection process.

Traditionally, Preimplantation Genetic Testing (PGT) has been used to screen embryos for genetic abnormalities before implantation, helping doctors select the healthiest embryos and thereby reducing the risk of miscarriage, IVF failure, and birth defects.

However, conventional PGT requires a biopsy, where cells are extracted from the embryo for testing. While effective, this process can introduce some risk and stress to the embryo.

The new niPGT method, now available at Orchid Fertility, eliminates the need for a biopsy altogether. Instead, it analyzes the DNA that embryos naturally release into the culture medium as they develop.

This non-invasive approach allows specialists to detect chromosomal abnormalities without compromising the structural integrity of the embryo, making the process safer and less stressful for both the embryo and the prospective parents.

Dr. Dimitrios Kafetzis, Medical Director at Orchid Fertility Dubai, emphasizes that niPGT gives patients peace of mind by providing essential genetic information without any added risk to the embryo.

This advancement is particularly beneficial for women over 35 and those who have experienced multiple failed IVF cycles due to unexplained implantation failures.

Orchid Fertility offers a comprehensive suite of genetic screening services, including PGT-A for chromosomal abnormalities such as Down syndrome, PGT-M for single-gene disorders like sickle cell anemia and cystic fibrosis, PGT-SR for chromosomal translocations, and Carrier Screening for inherited conditions.

While niPGT serves as a screening tool rather than a direct substitute for PGT-A, it works in tandem with advanced embryoscopes to help select the best embryos for implantation.

Beyond technology, Orchid Fertility is recognized for its holistic and personalized approach to fertility care.

 The clinic integrates medical expertise with emotional support, lifestyle guidance, and dietary advice, acknowledging that successful fertility treatment involves more than just medical intervention.

Each couple receives a tailored care plan that addresses their unique physical, emotional, and psychological needs, ensuring a supportive environment throughout their fertility journey.

The cost of fertility treatments in the UAE can be significant, with IVF and related procedures reaching upwards of US$27,000 before a successful pregnancy.

Orchid Fertility distinguishes itself by offering transparent, individualized treatment plans rather than bundled packages, ensuring that each patient receives care suited to their specific circumstances.

Accredited by international bodies and staffed by a team of experienced reproductive specialists, Orchid Fertility remains committed to evidence-based treatments and the highest standards of patient care.

Their mission is to help couples achieve healthy pregnancies and build strong families, all while prioritizing the overall well-being of their patients.